Skip to main content

Table 2 Cox proportional hazard regression illustrating the risk of cardiovascular mortality during 6.7 years of follow-up of the study population having a high plasma concentration of adiponectin

From: Gender difference in adiponectin associated with cardiovascular mortality

Variables   Total population   Males    Females   
  Hazard ratio 95 % CI p-value Hazard ratio 95 % CI p-value Hazard ratio 95 % CI p-value
Age 1.12 1.03–1.21 0.005 1.17 1.06–1.30 0.002 1.10 0.93–1.30 0.26
Hypertension 1.28 0.69–2.39 0.43 1.38 0.68–2.81 0.37 1.05 0.27–4,23 0.94
IHD 1.03 0.56–1.92 0.92 0.72 0.34–1.54 0.40 1.57 0.47–5.22 0.46
BMI 0.99 0.92–1.05 0.69 0.93 0.83–1.03 0.17 1.12 1.00–1.24 0.04
CRP 0.99 0.93–1.05 0.79 0.99 0.94–1.04 0.59 0.90 0.67–1.20 0.48
b-glucose 1.14 0.97–1.35 0.11 0.94 0.80–1.11 0.49 1.12 0.99–1.27 0.07
s-HDL 0.61 0.29–1.28 0.19 1.08 0.39–3.07 0.89 0.55 0.11–2.70 0.47
eGFR < 60 mL/min 0.72 0.34–1.55 0.40 0.66 0.28–1.55 0.34 0.78 0.12–5.19 0.79
Hb < 120 g/L 1.13 0.54–2.34 0.75 0.84 0.28–2.53 0.76 2.41 0.71–8.14 0.16
EF < 40 % 1.74 0.81–3.74 0.16 2.37 0.97–5.77 0.06 0.63 0.12–3.38 0.59
NT-proBNP Q4 (>197 ng/L) 2.54 1.21–5.34 0.01 1.62 0.67–3.89 0.28 6.30 1.36–29.14 0.02
Adiponectin Q4 (>12800 pg/mL) 2.35 1.15–4.82 0.02 1.66 0.38–7.26 0.50 5.28 1.59–17.57 0.007
  1. Notes: BMI: Body mass index; CI: Confidence interval: CRP: C-reactive protein; EF: Ejection fraction; eGFR: Estimated glomerular filtration rate; HDL: High density lipoproteins; NT-proBNP: N-terminal fragment of proBNP; Q: Quartile